期刊文献+

pIRES2-EGFP-BMP-2真核表达质粒的构建及其活性测定 被引量:5

Construction of the pIRES2-EGFP-BMP-2 plasmid and study on its transcriptional activity
下载PDF
导出
摘要 目的:构建pIRES2-绿色荧光蛋白(EGFP)-骨形成蛋白2(bone morphogenetic protein 2,BMP-2)真核表达质粒,并检测其表达活性。方法:采用逆转录聚合酶链式反应(RT-PCR)技术从人骨肉瘤组织中扩增出人骨形态发生蛋白2(hBMP-2)的基因片段,构建成pIRES2-EGFP-BMP-2重组质粒,经酶切、测序检测其构建的正确性,通过转染3T3细胞后分别采用RT-PCR、免疫组化及Western免疫印迹(Western blotting,WB)法检测其转录、表达活性。结果:构建的pIRES2-EGFP-BMP-2质粒经酶切、测序、RT-PCR、免疫组化、EGFP表达鉴定、WB等检验表明质粒构建成功并具有转录活性。结论:本实验成功构建了具有表达活性的hBMP-2真核表达质粒,为进一步研究用BMP-2基因转染的方法来促进实验动物骨折的愈合奠定了基础。 Objective: The purpose of this study was to construct the plRES2-EGFP-BMP-2 plasmid of hu- man and explore the feasibility of introducing bone morphogenetic protein 2(BMP-2)gene into 3T3 cell and the function of introduced gene in 3T3 cell. Methods: pIRES2 EGFP-BMP-2 plasmids were constructed, identified and then introduced into 3T3 cell. RT PCR,IH and WB were done to detect the integration of BMP-2 gene in 3T3 cell. Results: The successful construction of pIRES2-EGFP-BMP2 plasmids were con- firmed by the identification of endonuclease cutting,PCR,EGFP protein,IH and WB. RT PCR demonstrated the specific bands of BMP-2 cDNA in 3T3 cell. WB and IH confirm the expression of BMP-2 protein in cell. Conclusion: The exogenous human BMP-2 gene could be introduced into 3T3 cell. The introduced BMP-2 gene was able to replicate itself and express its protein in 3T3 cell. Our results provided a new pIRES2-EGFP-BMP-2 plasmid and gave us an opportunity to study more.
出处 《新疆医科大学学报》 CAS 2008年第5期524-527,共4页 Journal of Xinjiang Medical University
关键词 人类 PIRES2-EGFP 骨形成蛋白2 基因 human pIRES2-EGFP plasmid bone morphogenetic protein 2(BMP-2) gene
  • 相关文献

参考文献4

  • 1Steinert AF, Palmer GD, Evans CH. Gene therapy in the musculoskeletal system[J]. Curr Opin Orthop, 2004,15 :318- 324.
  • 2郭书权,许建中.BMP-2诱导成骨及传送的研究进展[J].第三军医大学学报,2005,27(16):1707-1710. 被引量:18
  • 3Zhang Y, Sekirov L, Saravolac E, et al. Stabilized plasmidlipid particles for regional gene therapy: formulation and trans fection properties[J]. Gene Ther, 1999,6 : 1438-1447.
  • 4Evans CH, Ghivizzani SC, Robbins PD, et al. The 2003 nicolas andry award orthopaedic gene therapy[J]. Clin Orthopaed Rel Res, 2004, 429:316-329.

二级参考文献20

  • 1Nussenbaum B, Teknos T N, Chepeha D B. Tissue engineering: the current status of this futuristic modality in head neck reconstruction[J]. Curr Opin Otolaryngol Head Neck Surg, 2004, 12(4): 311-315.
  • 2Nohe A, Keating E, Underhill T M, et al. Effect of the distribution and clustering of the type Ⅰ A BMP receptor ( ALK3 ) with the type ⅡBMP receptor on the activation of signalling pathways [ J ]. J Cell Sci,2003, 116(Pt 16): 3277 -3284.
  • 3Sowa H, Kaji H, Hendy G N, et al. Menin is required for bone morphogenetic protein 2-and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2[J]. J Biol Chem, 2004 , 279(39): 40267 -40275.
  • 4Iwasaki S, Iguchi M, Watanabe K, et al. Specific activation of the p38mitogen-activated protein kinase signaling pathway and induction of neurite outgrowth in PC12 cells by bone morphogenetic protein-2[ J]. J Biol Chem, 1999, 274(37): 26503 -26510.
  • 5Lemonnier J, Ghayor C, Guicheux J, et al. Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation[ J]. J Biol Chem, 2004, 279(1):259-264.
  • 6Ohyama Y, Nifuji A, Maeda Y, et al. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis [ J ]. Endocrinology, 2004, 145(10): 4685 -4692.
  • 7Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells[J]. J Cell Physiol, 2004, 200(3): 400-406.
  • 8Cheng H, Jiang W, Phillips F M, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs) [ J]. J Bone Joint Surg Am, 2003, 85 - A(8): 1544 - 1552.
  • 9Jorgensen N R, Henriksen Z, Sorensen O H, et al. Dexamethasone,BMP-2, and 1, 25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts [ J ]. Steroids, 2004, 69 (4): 219- 226.
  • 10Osyczka A M, Diefenderfer D L, Bhargave G, et al. Different effects of BMP-2 on marrow stromal cells from human and rat bone[J]. Cells Tissues Organs, 2004, 176( 1 -3): 109 - 119.

共引文献17

同被引文献70

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部